CATENA, Cristiana
 Distribuzione geografica
Continente #
NA - Nord America 15.535
EU - Europa 4.700
AS - Asia 942
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 6
AF - Africa 2
OC - Oceania 2
Totale 21.209
Nazione #
US - Stati Uniti d'America 15.444
UA - Ucraina 1.819
IT - Italia 848
DE - Germania 706
CN - Cina 668
FI - Finlandia 562
IE - Irlanda 309
SE - Svezia 185
TR - Turchia 162
CA - Canada 87
BE - Belgio 81
GB - Regno Unito 58
VN - Vietnam 54
FR - Francia 30
RU - Federazione Russa 29
EU - Europa 21
NL - Olanda 15
IR - Iran 14
ES - Italia 13
KR - Corea 11
IN - India 9
AT - Austria 8
JP - Giappone 6
CZ - Repubblica Ceca 5
TW - Taiwan 5
EE - Estonia 4
PL - Polonia 4
RS - Serbia 4
CH - Svizzera 3
IL - Israele 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BT - Bhutan 2
CL - Cile 2
HR - Croazia 2
ME - Montenegro 2
MX - Messico 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
DK - Danimarca 1
EG - Egitto 1
GL - Groenlandia 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 21.209
Città #
Woodbridge 2.091
Fairfield 1.829
Ann Arbor 1.474
Jacksonville 1.304
Houston 1.111
Chandler 975
Dearborn 788
Wilmington 781
Ashburn 764
Seattle 711
Cambridge 648
Princeton 336
Dublin 307
Beijing 292
Udine 169
Izmir 161
San Diego 128
Ottawa 78
Des Moines 74
Brussels 72
Hefei 64
Norwalk 64
Dong Ket 53
Milan 53
Nanjing 51
Kunming 49
Boardman 47
Redmond 47
San Mateo 45
Philadelphia 36
Rome 34
Grafing 25
Guangzhou 25
Falls Church 24
Helsinki 18
Jinan 18
Washington 18
Mcallen 13
Fuzhou 12
Trieste 12
Indiana 11
Nanchang 11
Pignone 11
Hebei 10
Wuhan 10
Phoenix 8
Saint Petersburg 8
Vicenza 8
Xian 8
Andover 7
Bitetto 7
Hangzhou 7
Leawood 7
Taranto 7
Turin 7
Vienna 7
Baotou 6
Chongqing 6
Nanning 6
Palermo 6
Shenyang 6
Simi Valley 6
Torre Del Greco 6
Bologna 5
Castellammare Di Stabia 5
Changsha 5
Chengdu 5
Henderson 5
Madrid 5
Paris 5
Taipei 5
Venezia 5
Zhengzhou 5
Augusta 4
Bari 4
Belgrade 4
Brno 4
Catania 4
Frankfurt am Main 4
Lanzhou 4
Mascali 4
Maserada sul Piave 4
Mumbai 4
San Giuseppe Vesuviano 4
Taizhou 4
Tallinn 4
Tappahannock 4
Tokyo 4
Toronto 4
Wenzhou 4
Amsterdam 3
Ardabil 3
Cantu 3
Edinburgh 3
Ferrara 3
Fontanafredda 3
Harbin 3
Maserada Sul Piave 3
Murano 3
Ningbo 3
Totale 15.125
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 236
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 151
Aldosterone and the heart: from basic research to clinical evidence 142
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 139
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 134
Aldosterone and Left Ventricular Remodeling 130
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 130
Abnormalities of insulin receptors in spontaneously hypertensive rats 127
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 126
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 123
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 123
Aldosterone and the heart: still an unresolved issue? 121
Aldosterone, Organ Damage, and Dietary Salt 120
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 120
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 119
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 118
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 115
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 115
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 114
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 114
Treatment of primary aldosteronism and organ protection 114
Prohypertensive effect of insulin: possible role of the sympathetic system 113
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 112
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 112
The emergent cardiovascular risk factors and organ damage in arterial hypertension 112
Cardiovascular outcomes in patients with primary aldosteronism after treatment 112
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 112
Benzodiazepines: an old class of new antihypertensive drugs? 111
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 111
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 111
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 110
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 110
Spontaneous restoration of sinus rhythm after cardiac surgery 110
Kidney in primary aldosteronism: a key determinant of treatment outcome 109
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 109
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 109
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 108
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 108
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 108
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 106
Benign familial macrocytosis 106
Salt, hypertension, and cardiovascular disease 106
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 105
Abnormalities of glucose metabolism in patients with early renal failure 105
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 104
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 104
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 104
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 102
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 101
Renal function in primary aldosteronism 101
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 101
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 100
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 100
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 100
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 100
Diabetes, diabetic complications, and blood pressure targets 99
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 99
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 99
The SPARTACUS Trial: Controversies and Unresolved Issues 98
Potassium-sparing diuretics in hypertension 97
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 97
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 97
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 96
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 96
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 96
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 95
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 95
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 94
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 94
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 94
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study 93
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 92
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 91
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 91
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 91
Uricaemia and left ventricular mass in hypertensive patients 91
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 90
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 90
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial 90
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 89
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 89
Glucose metabolism in early renal failure 88
Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension 88
NON-ALCOHOLIC FATTY LIVER DISEASE IS NOT ASSOCIATED WITH VITAMIN D DEFICIENCY IN ESSENTIAL HYPERTENSION 88
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 88
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 88
Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension 88
Primary hyperparathyroidism in pregnancy 88
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 87
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension 87
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 87
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: The EPATH trial 87
Oxidative Stress Is Activated by Free Fatty Acids in Cultured Human Hepatocytes 87
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 86
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 86
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 86
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 86
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial 86
Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events 86
Increased serum lipoprotein(a) levels in patients with early renal failure 85
Totale 10.458
Categoria #
all - tutte 56.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.969


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.843 0 0 0 0 17 5 30 320 17 260 739 455
2019/20205.946 286 278 183 819 413 1.098 706 731 379 502 108 443
2020/20213.703 107 394 93 497 97 497 198 431 642 131 432 184
2021/20222.474 103 289 98 182 69 88 145 160 26 414 474 426
2022/20232.670 371 118 36 299 234 781 19 170 382 55 103 102
2023/2024509 146 78 57 47 181 0 0 0 0 0 0 0
Totale 22.055